LGD-4033 (ligandrol) has high affinity for the androgen receptor (AR). By selectively modulating their response, favours anabolic effect allowing growth, regeneration and subsequent preservation of muscle tissue as well as enhances bone mineralization.
Ligandrol not subject to aromatization, or conversion to DHT. Thus, its use does not lead to unwanted consequences, attributed to excessive concentrations of testosterone. It does not affect the same as changing the condition of the prostate, and skin, does not cause mood swings and minimizes the risk of a possible gynecomastia.
4 - ((R) -2 - ((R) -2,2,2-trifluoro-1-hydroxyethyl) pyrrolidin-1-yl) -2-trifluoromethyl) -benzonitrile in a portion of less than 5 mg / day seems to be well tolerated by the body. Taking into account that the safe portion does not adversely affect the level of luteinizing hormone (LH), follicle stimulating hormone (FSH) and total testosterone levels, leaving its the value of the standard range. Not affects: blood pressure, hematocrit, hemoglobin or lipid profile, although the taking of higher amounts can lead to a temporary reduction in HDL cholesterol levels, returning to normal shortly after the end of the cycle.